CWM
MRNA icon

Centricity Wealth Management’s Moderna MRNA Stock Holding History

Centricity Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.89K Hold
141
– – ﹤0.01% 388
2025
Q1 		$4K Hold
141
– – ﹤0.01% 388
2024
Q4 		$5.86K Buy
+141
New +$6.74K 0.01% 372

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Centricity Wealth Management's MRNA Position: Q2 2025 in Review

Centricity Wealth Management held its Moderna (MRNA) position steady in Q2 2025 at 141 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Centricity Wealth Management first reported a position in MRNA in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.86K in Q4 2024. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Centricity Wealth Management held 141 shares of Moderna worth $3.89K as of Q2 2025.
  • Centricity Wealth Management left its Moderna share count unchanged in Q2 2025.
  • Moderna made up ﹤0.01% of Centricity Wealth Management's portfolio in Q2 2025, its #388 holding.
  • Centricity Wealth Management first reported a position in Moderna in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's Moderna position peaked at $5.86K in Q4 2024.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.